Patent · US Active

Detection of MET exon 14 deletions and associated therapies

US11913072B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2017
Grant dateFeb 27, 2024
Priority date—
Expiry dateMay 11, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are methods and compositions to detect MET exon 14 skipping using RT-PCR, and methods of treating individuals with MET exon 14 deleted cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.